跳至主要内容
临床试验/NCT02762019
NCT02762019已完成3 期

LAMPO: Multicenter Randomized Double-blind Controlled Trial to Evaluate the Efficacy of Laser Therapy for Treatment of Oral Mucositis Induced by Chemotherapy in Children

IRCCS Burlo Garofolo8 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
101
试验地点
8
主要终点
Reduction of the grade of oral mucositis

研究概览

简要总结

Children with cancer undergoing intensive chemotherapy (CT) regimens experience many side effects among which oral mucositis (OM) is one of the most debilitating. Modifications of CT's schedule and prolonged hospitalization may be necessary in presence of OM, causing poor general conditions and debilitation. Moreover, the use of narcotic analgesics and total parenteral nutrition may be required, triggering not only a physical deficit but also an economic burden. Despite the frequency and impact of OM among children with cancer, there is no consensus on standard therapy for this condition. Previous studies demonstrated that high power laser therapy can help the maintenance of nutritional status in patients with OM and can remarkably reduce costs/resources needed. Laser therapy has evidence of efficacy in reducing symptoms and in preventing the onset of OM in adult cancer patients but only one randomized controlled trial, with a limited number of children enrolled, supports its use in children for treatment of OM induced by chemotherapy.

This multicenter double-blind randomized controlled trial evaluates the efficacy of laser for treatment of oral mucositis secondary to chemotherapy in children aged 3-17 years.

The study involves 8 italian hospitals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
3 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children aged 3-18 years
  • Oral mucositis of grade 3 or 4 at enrollment (CTC - WHO scale)
  • Antiblastic chemotherapy in the in the previous three weeks
  • Willingness to undergo treatment for 4 consecutive days and to return for evaluation 7 and 11 days after enrollment.

排除标准

  • Previous treatment with laser therapy for stomatitis
  • Presence of dysplastic oral lesions
  • Reduction of mouth opening (<1 cm)
  • Localized head and/or neck radiation treatment in the previous 4 weeks
  • Use of keratinocyte growth factor (KGF)
  • Previous enrollment in the study

结局指标

主要结局

Reduction of the grade of oral mucositis

时间窗: 7 days after enrollment

Reduction of stomatitis' grade (from grade 3 or 4 to a lower grade). The grade of stomatitis is defined using the World Health Organization (WHO) evaluation scale

次要结局

  • Reduction of pain, age 4-7 years(11 days after enrollment)
  • Reduction of need for analgesics(at day 7)
  • Reduction of the grade of oral mucositis(11 days after enrollment)
  • Reduction of pain, age 8-18 years(11 days after enrollment)
  • Adverse events(at day 11)

研究者

发起方
IRCCS Burlo Garofolo
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronfani Luca

MD, PhD

IRCCS Burlo Garofolo

研究点 (8)

Loading locations...

相似试验